CERS
CERUS CORP
NASDAQ · Healthcare · Medical - Devices · US
$2.47
+5.34%Margins
Gross margin
51.8%
EBITDA margin
0.3%
EBIT margin
-1.1%
Net margin
-3.2%
FCF margin
0.2%
-9.7%
Return on equity
-3.6%
Return on assets
-2.1%
Return on invested capital
1.11x
Asset turnover
$3.5M
Cash from operations
$0.28
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Sep 1, 2026